Cloning and the Debate on Abortion
By Nigel Cameron and Lori Andrews,
Chicago Tribune
| 08. 08. 2001
Italian fertility specialist Severino Antinori has announced
that he will begin human cloning in early 2002. Two hundred
couples desperately seeking to create children will become human
guinea pigs in a massive experiment. The odds are not in their
favor. In animals, cloning currently only results in a successful
pregnancy 3 to 5 percent of the time. And, even in those rare
instances, many of the resulting offspring suffer. One-third
die shortly before or right after birth. Other cloned animals
seem perfectly healthy at first and then suffer heart and blood
vessel problems, underdeveloped lungs, diabetes, immune system
deficiencies and severe growth abnormalities.
If an infectious disease were killing one-third of human infants,
we would declare it a public health emergency. We certainly
wouldn’t set up a clinic to enable it to happen. Yet despite
these grave risks, only five states have laws banning human
cloning. There is no federal law on the subject yet. Despite
widespread public opposition to human cloning, various researchers
and biotech companies have so far prevented the passage of such
a law.
This summer, however...
Related Articles
By Antonio Regalado, MIT Technology Review | 03.20.2024
There is a new most expensive drug ever—a gene therapy that costs as much as a Brooklyn brownstone or a Miami mansion, and more than the average person will earn in a lifetime.
Lenmeldy is a gene treatment for metachromatic...
By Carl Zimmer, The New York Times | 03.10.2024
In 1889, a French doctor named Francois-Gilbert Viault climbed down from a mountain in the Andes, drew blood from his arm and inspected it under a microscope. Dr. Viault’s red blood cells, which ferry oxygen, had surged 42 percent. He...
By Billy Perrigo, TIME | 03.11.2024
The U.S. government must move “quickly and decisively” to avert substantial national security risks stemming from artificial intelligence (AI) which could, in the worst case, cause an “extinction-level threat to the human species,” says a report commissioned by the U.S...
By Gerry Smith, Bloomberg | 03.12.2024
When Celenise Mahmood first learned about two new gene therapies that could cure sickle cell disease, she felt a wave of relief.
Her 9-year-old son, Navid, has the inherited blood disorder. By age 5, he’d had over 30 life-saving blood...